Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

On the Road Again

(LSC, Pixabay)

21 April 2016. We’ll be traveling for the rest of the week, so Science & Enterprise will not have any posts today or Friday. We’ll resume our regular posting on Monday, 25 April.

* * *

NIH Closes Two Clinical Facilities for Sterility Issues

National Cancer Institute in Rockville, Maryland (NIH, Flickr)

20 April 2016. National Institutes of Health closed two of its clinical facilities found not in compliance with safety and quality standards that could put patients at risk. Facilities at NIH closed for not meeting Current Good Manufacturing Practice standards are a cell therapy production . . . → Read More: NIH Closes Two Clinical Facilities for Sterility Issues

U.S. Energy Use Declines in 2015, Renewables Gain

(DoDLive.mil)

20 April 2016. Energy use by Americans in their homes and businesses declined in 2015 from the previous year, due to a sharp drop in coal burned for electric power, among other factors. The findings were published in an annual accounting of national energy supply and demand by Lawrence Livermore National Laboratory, . . . → Read More: U.S. Energy Use Declines in 2015, Renewables Gain

Software Detects DNA Mutations in Single Cells

(National Human Genome Research Institute, NIH)

19 April 2016. A new computer program detects genetic variations in individual cells, rather than current methods that require analyzing DNA in millions of cells. The program, named Monovar, is described by geneticists and bioinformatics specialists at M.D. Anderson Cancer Center in the 18 April issue of . . . → Read More: Software Detects DNA Mutations in Single Cells

Nanoparticles Designed for Asthma, Allergy Treatments

(Oleg Savitsky, Wikimedia Commons)

19 April 2016. A technique for masking allergy or asthma treatments in biodegradable nanoparticles is shown in lab mice to quickly build a tolerance in the immune system for offending allergens. A medical and engineering team at Northwestern University in Chicago published its findings yesterday, 18 April, in Proceedings . . . → Read More: Nanoparticles Designed for Asthma, Allergy Treatments

Electric Current Shown to Reduce Wound Bacteria

Pseudomonas aeruginosa bacteria (National Institute of Environmental Health Sciences, NIH)

18 April 2016. A bandage that sends a mild electric current through wounds was shown in tests with pigs to disrupt and reduce films of bacteria that form over wounds, to improve healing. Tests of the electric wound dressing, made by Vomaris Innovations . . . → Read More: Electric Current Shown to Reduce Wound Bacteria

Therapy Shown to Boost Immune System Against Cancer

Carcinoid lung tumor (Yale Rose, Flickr)

18 April 2016. An experimental treatment was shown in lab mice to enhance immune system cells that can help immunotherapy drugs to reduce solid tumor growth. Researchers from Memorial Sloan Kettering Cancer Center in New York and Infinity Pharmaceuticals in Cambridge, Massachusetts presented their findings yesterday (17 . . . → Read More: Therapy Shown to Boost Immune System Against Cancer

Challenge Seeks Diabetic Kidney Disease Treatments

(stevepb, Pixabay)

15 April 2016. A challenge on InnoCentive is asking for new techniques to deliver drugs to specialized kidney cells in patients with kidney damage caused by diabetes. The competition has a total purse of $20,000 and a deadline of 13 May 2016 for submissions. The sponsor of the challenge, pharmaceutical company . . . → Read More: Challenge Seeks Diabetic Kidney Disease Treatments

Implanted Device Delivers Pancreatic Cancer Drugs

Pancreatic cancer device inventors, L-R, Matteo Ligorio, Laura Indolfi, and Elazer Edelman (Bryce Vickmark, MIT)

15 April 2016. An engineering and medical research team developed an implanted device that in lab mice delivers chemotherapy directly to cancerous tumors in the pancreas. The device, designed in a biomedical engineering lab at Massachusetts Institute of . . . → Read More: Implanted Device Delivers Pancreatic Cancer Drugs

Emergency Snakebite Treatment in Development

Western diamondback rattlesnake (H. Krisp, Wikimedia Commons)

14 April 2016. A new treatment for rattlesnake bites, designed as emergency first-aid until reaching a clinic, is being developed at University of Arizona medical school in Tucson. The therapy, still in preclinical stages, is the work of anesthesiology professor Vance Nielsen and toxicologist Leslie Boyer, . . . → Read More: Emergency Snakebite Treatment in Development